Background The purpose of the study was to determine the role of fecal calprotectin and
lactoferrin in the prediction of inflammatory bowel disease relapses, both in patients with …

OBJECTIVES: Immunomodulators are used as maintenance treatment of inflammatory bowel
disease (IBD). Data regarding their possible effects in the course of pregnancy when the …

Aim: Anti-tumor necrosis factor (TNF)-alpha agents are widely used for the treatment of both
inflammatory bowel disease (IBD) and psoriasis. Psoriatic skin lesions induced by anti-TNF …

Background The aim was to evaluate the efficacy and tolerance of oral and intravenous iron
treatment in anemic inflammatory bowel disease (IBD) patients, considering both …

Background and Aims The development programm UNIFI has shown promising results of
ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in clinical practice. …

Background The effectiveness of the switch to another anti–tumor necrosis factor (anti-TNF)
agent is not known. The aim of this study was to analyze the effectiveness and safety of …

Background Anti–tumor necrosis factor agents (anti-TNFs) are efficacious at preventing the
postoperative recurrence (POR) of Crohn disease, as demonstrated in 2 randomized …

Background and Aims Clinical trials and real-life studies with ustekinumab in Crohn’s disease
[CD] have revealed a good efficacy and safety profile. However, these data are scarcely …

Background The long‐term outcome of patients after antitumour necrosis factor alpha (anti‐TNF)
discontinuation is not well known. Aims To assess the risk of relapse in the long‐term …

BACKGROUND: Efficacy of infliximab in Crohn's disease (CD) showed by randomized controlled
trials must be confirmed in clinical practice. We aimed to evaluate efficacy and safety of …